Identification of a Syndrome Class of Neuropsychiatric Adverse Reactions to Mefloquine from Latent Class Modeling of FDA Adverse Event Reporting System Data

Ítems similars

• A serious nightmare: psychiatric and neurologic adverse reactions to mefloquine are serious adverse reactions
  per: Nevin, Remington L.
  Publicat: (2017)
• FDA Black Box, VA Red Ink? A Successful Service-Connected Disability Claim for Chronic Neuropsychiatric Adverse Effects From Mefloquine
  per: Nevin, Remington L., et al.
  Publicat: (2016)
• Latent classes of neuropsychiatric symptoms in NACC controls and conversion to MCI or dementia
  per: Leoutsakos, Jeannie-Marie S., et al.
  Publicat: (2015)
• Neuropsychiatric Adverse Reactions to Mefloquine: a Systematic Comparison of Prescribing and Patient Safety Guidance in the US, UK, Ireland, Australia, New Zealand, and Canada
  per: Nevin, Remington L., et al.
  Publicat: (2016)
• Analysis of postmarketing neuropsychiatric adverse events of avapritinib based on the FDA adverse event reporting system
  per: Wei Mao, et al.
  Publicat: (2025-01-01)